Mayo Clin­ic launch­es clin­i­cal an­a­lyt­ics plat­form with nfer­ence; WuXi buys Ger­man plant from Bay­er

→ Mayo Clin­ic is open­ing up its sprawl­ing clin­i­cal data­base to nfer­ence, the Cam­bridge, MA-based AI start­up it’s long part­nered with and re­cent­ly backed in a $60 mil­lion round. The project aims to dig­i­tize 25 mil­lion tis­sue slides with­in the next 2 to 2.5 years, Fierce­Biotech re­port­ed, in ad­di­tion to an­no­tat­ing, link­ing and tag­ging writ­ten physi­cian notes. Af­ter sort­ing through the da­ta, nfer­ence will use the plat­form to iden­ti­fy new tar­gets and bio­mark­ers as well as ap­ply it in clin­i­cal tri­al re­cruit­ment and re­al-world ev­i­dence gen­er­a­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER